Truqap is a kinase inhibitor that actually works by blocking pathways that enable the most cancers cells survive and improve, so cuts down most cancers progress. Truqap is from a category of medicines called an AKT inhibitor. Truqap obtained FDA approval on November 17, 2023, following positive final results through https://robertr998fqa1.blogpayz.com/profile